Emad L. Izake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emad L. Izake has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Godwin Adefikayo Ayoko
School of Chemistry and Physics, Queensland University of Technology (QUT), 2 George Street, Brisbane, QLD, 4000, Australia
16 shared publications - Esa Jaatinen
Queensland University of Technology
12 shared publications Peter M. Fredericks
12 shared publicationsBiju Cletus
11 shared publicationsWilliam Olds
Queensland Univ. of Technology (Australia)
11 shared publications- Mahnaz D. Gholami
Queensland Pharmaceutical Manufacturing Service, Central Pharmacy Queensland Health Richlands Australia
9 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 470
Interference-free aptasensor for the sensitive determination of cardiac troponin I: Towards rapid diagnosis of myocardial infarction
- 19 September 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 470
Open AccessInterference-free aptasensor for the sensitive determination of cardiac troponin I: Towards rapid diagnosis of myocardial infarction
- Open Access
- 30 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1095
Aerosolized Quercetin-Loaded Chia Seed Polysaccharide Nanoparticles: Design of Experiments and Machine-Learning-Guided Optimization for Enhanced Lung Cancer Cell Delivery
Background/Objectives: The recent advances in pulmonary delivery have shifted the paradigm to the development of inhalable drug-loaded polysaccharide particles that can be positioned at the respiratory interface while reducing the systemic exposure. Quercetin has broad anticancer activity but remains difficult to translate because of its poor aqueous solubility, limited bioavailability and rapid metabolic loss. Here, we report quercetin-loaded chitosan/Salvia hispanica polysaccharide nanoparticles as a natural polyelectrolyte nanocarrier for pulmonary delivery in lung cancer. Methods: Central composite design (CCD) and artificial neural network (ANN) models were used for mapping the factors to responses. Results: The models displayed a higher predictive accuracy and optimization reliability for identifying the optimized formulation. The optimized nanoparticles showed a quasi-spherical morphology (mean hydrodynamic diameter = 331 ± 14.34 nm) with cationic ζ-potential of +36.3 ± 2.56 mV and polydispersity index of 0.15. The optimized formulation showed acceptable powder-flow characteristics, an encapsulation efficiency of 73.8 ± 0.73%, drug loading of 14.20 ± 0.22%, and biphasic release with sustained quercetin release over 48 h. In A549 and H460 cell lines, nanoencapsulation increased the antiproliferative effect of quercetin relative to the free compound, yielding lower IC50 values after 48 h of exposure. The nanoparticles showed greater suppression of wound closure, increased reactive oxygen species fluorescence and clear cellular uptake. Blank nanoparticles produced only limited effects. Conclusions: These results indicate that CCD/ANN-guided chitosan/Salvia hispanica polysaccharide nanoparticles provide a promising nanodelivery tool for quercetin delivery and enhanced in vitro activity in lung cancer cells, while the observed aerosol performance advocates further investigation of their pulmonary delivery potential.
- 30 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1095
Open AccessAerosolized Quercetin-Loaded Chia Seed Polysaccharide Nanoparticles: Design of Experiments and Machine-Learning-Guided Optimization for Enhanced Lung Cancer Cell Delivery
Background/Objectives: The recent advances in pulmonary delivery have shifted the paradigm to the development of inhalable drug-loaded polysaccharide particles that can be positioned at the respiratory interface while reducing the systemic exposure. Quercetin has broad anticancer activity but remains difficult to translate because of its poor aqueous solubility, limited bioavailability and rapid metabolic loss. Here, we report quercetin-loaded chitosan/Salvia hispanica polysaccharide nanoparticles as a natural polyelectrolyte nanocarrier for pulmonary delivery in lung cancer. Methods: Central composite design (CCD) and artificial neural network (ANN) models were used for mapping the factors to responses. Results: The models displayed a higher predictive accuracy and optimization reliability for identifying the optimized formulation. The optimized nanoparticles showed a quasi-spherical morphology (mean hydrodynamic diameter = 331 ± 14.34 nm) with cationic ζ-potential of +36.3 ± 2.56 mV and polydispersity index of 0.15. The optimized formulation showed acceptable powder-flow characteristics, an encapsulation efficiency of 73.8 ± 0.73%, drug loading of 14.20 ± 0.22%, and biphasic release with sustained quercetin release over 48 h. In A549 and H460 cell lines, nanoencapsulation increased the antiproliferative effect of quercetin relative to the free compound, yielding lower IC50 values after 48 h of exposure. The nanoparticles showed greater suppression of wound closure, increased reactive oxygen species fluorescence and clear cellular uptake. Blank nanoparticles produced only limited effects. Conclusions: These results indicate that CCD/ANN-guided chitosan/Salvia hispanica polysaccharide nanoparticles provide a promising nanodelivery tool for quercetin delivery and enhanced in vitro activity in lung cancer cells, while the observed aerosol performance advocates further investigation of their pulmonary delivery potential.
- Open Access
- 26 January 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (3) , 1060-1073
Nitrogen Positioning in Bicyclic Aromatic Ligands Governs Binding to Nano-Gold: A Curious Case of Quinolinethiol
- 26 January 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (3) , 1060-1073
Open AccessNitrogen Positioning in Bicyclic Aromatic Ligands Governs Binding to Nano-Gold: A Curious Case of Quinolinethiol
- Open Access
- 17 June 2025
- Published by Springer Nature in Journal of Analysis and Testing
- Vol. 9 (4) , 607-617
A New Disposable Paper-Based Chemosensor for the Rapid and Direct Detection of Hexavalent Chromium in Aqueous Media
Hexavalent chromium (Cr 6+ ) poses significant risks to both individuals and the environment. However, direct detection of Cr 6+ in fully aqueous media with high sensitivity and selectivity is extremely challenging. Herein, an isoindigo-derived chemosensor (II-MT) is developed and utilized as a single use paper-based sensor. This sensor allows for quick and simple screening of Cr 6+ in water through a significant color change that is visible to the naked eyes. Moreover, via a simple UV detection method, the new sensor enables an accurate trace-level detection of Cr 6+ at concentration as low as 0.1 µM. This detection capability is one order of magnitude lower than the recommended limit for drinking water (0.960 µM) set by World Health Organization (WHO). More importantly, the sensor delivers an average recovery of 104.5% and 98.25% for the detection of tap water samples. This convenient, yet accurate, quantification method for Cr 6+ in spiked tap water was compared to the certified inductive coupled plasma (ICP) method. The agreement between the measurements obtained by our sensor and the ICP method was 93.57%. Mechanistic studies using Fourier Transform Infrared Spectroscopy (FT-IR) indicate a nucleophilic attack to the carbonyl group of II-MT by HCrO 4 − , resulting in the dye color changing from brown to colorless. Overall, this novel chemosensor has a high potential for application as a selective, sensitive, and disposable paper sensor for direct and rapid screening of Cr 6+ in real world environments.
- 17 June 2025
- Published by Springer Nature in Journal of Analysis and Testing
- Vol. 9 (4) , 607-617
Open AccessA New Disposable Paper-Based Chemosensor for the Rapid and Direct Detection of Hexavalent Chromium in Aqueous Media
Hexavalent chromium (Cr 6+ ) poses significant risks to both individuals and the environment. However, direct detection of Cr 6+ in fully aqueous media with high sensitivity and selectivity is extremely challenging. Herein, an isoindigo-derived chemosensor (II-MT) is developed and utilized as a single use paper-based sensor. This sensor allows for quick and simple screening of Cr 6+ in water through a significant color change that is visible to the naked eyes. Moreover, via a simple UV detection method, the new sensor enables an accurate trace-level detection of Cr 6+ at concentration as low as 0.1 µM. This detection capability is one order of magnitude lower than the recommended limit for drinking water (0.960 µM) set by World Health Organization (WHO). More importantly, the sensor delivers an average recovery of 104.5% and 98.25% for the detection of tap water samples. This convenient, yet accurate, quantification method for Cr 6+ in spiked tap water was compared to the certified inductive coupled plasma (ICP) method. The agreement between the measurements obtained by our sensor and the ICP method was 93.57%. Mechanistic studies using Fourier Transform Infrared Spectroscopy (FT-IR) indicate a nucleophilic attack to the carbonyl group of II-MT by HCrO 4 − , resulting in the dye color changing from brown to colorless. Overall, this novel chemosensor has a high potential for application as a selective, sensitive, and disposable paper sensor for direct and rapid screening of Cr 6+ in real world environments.
- Open Access
- 22 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1506
Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation
Background: This study explores the development and characterization of spray-dried composite microparticles consisting of levofloxacin (LVX, a broad-spectrum antibiotic), and ambroxol (AMB, a mucolytic agent that has antibacterial and antibiofilm properties), for the intended application of the drug against lower respiratory tract infections (LRTIs). Methods: A range of LVX to AMB mass ratios (1:1, 1:0.5, and 1:0.25) were prepared, with and without the use of the dispersibility enhancer leucine (LEU), and spray-dried following pre-optimized parameters to achieve the required particle size (1–5 µm) and flow properties. The formulations were characterized by attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy, scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), and a thermogravimetric analysis (TGA). The in vitro aerosolization performance of the new formulation was evaluated with a twin-stage impinger (TSI) at a flow rate of 60 ± 5 L/min. Using a validated RP-HPLC method, LVX and AMB were quantitatively determined. Results: The combined spray-dried LVX, AMB, and LEU particles were spherically shaped with sizes ranging from 1.9 to 2.9 µm, thus complying with the size requirements for effective deep lung deposition. The dispersibility enhancer leucine produced a high yield and enhanced the flow properties and aerosolization characteristics of the spray-dried formulations. The LVX to AMB mass ratios showed a remarkable impact on the aerosolization properties, with the LVX to AMB 1:1 mass ratio demonstrating the best flow and FPFs for both drugs. There must be a balanced ratio of these components for spray drying the composite particles to obtain composite particles of the required size and with the appropriate flow property. The addition of 5% of LEU significantly (p < 0.005) improved the FPF of all the formulations, probably by enhancing the surface hydrophobicity of the composite particles. Conclusions: The spray-dried combined antibiotics formulation has a strong potential for efficient lung delivery intended for the management of LRTIs.
- 22 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1506
Open AccessDevelopment and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation
Background: This study explores the development and characterization of spray-dried composite microparticles consisting of levofloxacin (LVX, a broad-spectrum antibiotic), and ambroxol (AMB, a mucolytic agent that has antibacterial and antibiofilm properties), for the intended application of the drug against lower respiratory tract infections (LRTIs). Methods: A range of LVX to AMB mass ratios (1:1, 1:0.5, and 1:0.25) were prepared, with and without the use of the dispersibility enhancer leucine (LEU), and spray-dried following pre-optimized parameters to achieve the required particle size (1–5 µm) and flow properties. The formulations were characterized by attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy, scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), and a thermogravimetric analysis (TGA). The in vitro aerosolization performance of the new formulation was evaluated with a twin-stage impinger (TSI) at a flow rate of 60 ± 5 L/min. Using a validated RP-HPLC method, LVX and AMB were quantitatively determined. Results: The combined spray-dried LVX, AMB, and LEU particles were spherically shaped with sizes ranging from 1.9 to 2.9 µm, thus complying with the size requirements for effective deep lung deposition. The dispersibility enhancer leucine produced a high yield and enhanced the flow properties and aerosolization characteristics of the spray-dried formulations. The LVX to AMB mass ratios showed a remarkable impact on the aerosolization properties, with the LVX to AMB 1:1 mass ratio demonstrating the best flow and FPFs for both drugs. There must be a balanced ratio of these components for spray drying the composite particles to obtain composite particles of the required size and with the appropriate flow property. The addition of 5% of LEU significantly (p < 0.005) improved the FPF of all the formulations, probably by enhancing the surface hydrophobicity of the composite particles. Conclusions: The spray-dried combined antibiotics formulation has a strong potential for efficient lung delivery intended for the management of LRTIs.
- Open Access
- 10 June 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1316, 342861
Rapidly and simply detecting Cr (VI) in aqueous media via a diketopyrrolopyrrole-based chemosensor with both high selectivity and low LOD
- 10 June 2024
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1316, 342861
Open AccessRapidly and simply detecting Cr (VI) in aqueous media via a diketopyrrolopyrrole-based chemosensor with both high selectivity and low LOD
- Open Access
Paper electrochemical immunosensor for the rapid screening of Galectin-3 patients with heart failure
- Open Access
- 16 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 674
Impact of Leucine and Magnesium Stearate on the Physicochemical Properties and Aerosolization Behavior of Wet Milled Inhalable Ibuprofen Microparticles for Developing Dry Powder Inhaler Formulation
This study investigated the development and characterization of leucine and magnesium stearate (MgSt) embedded wet milled inhalable ibuprofen (IBF) dry powder inhaler (DPI) formulations. IBF microparticles were prepared by a wet milling homogenization process and were characterized by SEM, FTIR, DSC, XRD and TGA. Using a Twin-Stage Impinger (TSI), the in vitro aerosolization of the formulations with and without carrier lactose was studied at a flow rate of 60± 5 L/min and the IBF was determined using a validated HPLC method. The flow properties were determined by the Carr’s Index (CI), Hausner Ratio (HR) and Angle of Repose (AR) of the milled IBF with 4–6.25% leucine and leucine containing formulations showed higher flow property than those of formulations without leucine. The fine particle fraction (FPF) of IBF from the prepared formulations was significantly (p = 0.000278) higher (37.1 ± 3.8%) compared to the original drug (FPF 3.7 ± 0.9%) owing to the presence of leucine, which enhanced the aerosolization of the milled IBF particles. Using quantitative phase analysis, the XPRD data revealed the crystallinity and accurate weight percentages of the milled IBF in the formulations. FTIR revealed no changes of the structural integrity of the milled IBF in presence of leucine or MgSt. The presence of 2.5% MgSt in the selected formulations produced the highest solubility (252.8 ± 0.6 µg/mL) of IBF compared to that of unmilled IBF (147.4 ± 1.6 µg/mL). The drug dissolution from all formulations containing 4–6.25% leucine showed 12.2–18.6% drug release in 2.5 min; however, 100% IBF dissolution occurred in 2 h whereas around 50% original and dry milled IBF dissolved in 2 h. The results indicated the successful preparation of inhalable IBF microparticles by the wet milling method and the developed DPI formulations with enhanced aerosolization and solubility due to the presence of leucine may be considered as future IBF formulations for inhalation.
- 16 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 674
Open AccessImpact of Leucine and Magnesium Stearate on the Physicochemical Properties and Aerosolization Behavior of Wet Milled Inhalable Ibuprofen Microparticles for Developing Dry Powder Inhaler Formulation
This study investigated the development and characterization of leucine and magnesium stearate (MgSt) embedded wet milled inhalable ibuprofen (IBF) dry powder inhaler (DPI) formulations. IBF microparticles were prepared by a wet milling homogenization process and were characterized by SEM, FTIR, DSC, XRD and TGA. Using a Twin-Stage Impinger (TSI), the in vitro aerosolization of the formulations with and without carrier lactose was studied at a flow rate of 60± 5 L/min and the IBF was determined using a validated HPLC method. The flow properties were determined by the Carr’s Index (CI), Hausner Ratio (HR) and Angle of Repose (AR) of the milled IBF with 4–6.25% leucine and leucine containing formulations showed higher flow property than those of formulations without leucine. The fine particle fraction (FPF) of IBF from the prepared formulations was significantly (p = 0.000278) higher (37.1 ± 3.8%) compared to the original drug (FPF 3.7 ± 0.9%) owing to the presence of leucine, which enhanced the aerosolization of the milled IBF particles. Using quantitative phase analysis, the XPRD data revealed the crystallinity and accurate weight percentages of the milled IBF in the formulations. FTIR revealed no changes of the structural integrity of the milled IBF in presence of leucine or MgSt. The presence of 2.5% MgSt in the selected formulations produced the highest solubility (252.8 ± 0.6 µg/mL) of IBF compared to that of unmilled IBF (147.4 ± 1.6 µg/mL). The drug dissolution from all formulations containing 4–6.25% leucine showed 12.2–18.6% drug release in 2.5 min; however, 100% IBF dissolution occurred in 2 h whereas around 50% original and dry milled IBF dissolved in 2 h. The results indicated the successful preparation of inhalable IBF microparticles by the wet milling method and the developed DPI formulations with enhanced aerosolization and solubility due to the presence of leucine may be considered as future IBF formulations for inhalation.